Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016)
- Status
- COMPLETED
- Phase
- PHASE2
To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of MK0431 in Patients With Type 2 Diabetes (0431-010)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)
- Status
- COMPLETED
- Phase
- PHASE2
MK-0524B Lipid Study (MK-0524B-063)
- Status
- COMPLETED
- Phase
- PHASE3
Dose-Range Finding Study for MK0893 (0893-008)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)
- Status
- COMPLETED
- Phase
- PHASE3
Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe
- Status
- UNKNOWN
- Phase
- NA
A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
5-Alpha Reductase and Anabolic Effects of Testosterone
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017)
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616; Org 25969) in Elderly Participants With Adult Participants (MK-8616-029)
- Status
- COMPLETED
- Phase
- PHASE3
Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Recovery From Rocuronium 1.2 mg/kg Followed by Sugammadex (Org 25969) 16 mg/kg at 3 Minutes With Recovery From Succinylcholine 1.0 mg/kg (19.4.303)(P05946)(MK-8616-026)
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056)
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3